Evidence map›Paper›PMID 42209475›Full record

ArticleNature communications2026

In situ ptychographic nanotomography captures activation, mobility, and deactivation of supported catalysts.

Arik Beck, Mirko Holler, Tomas Aidukas, Andreas Menzel, Manuel Guizar-Sicairos, Jeroen A van Bokhoven, Johannes Ihli

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Arik BeckETH Zürich, Zürich, Switzerland. arik.beck@kit.edu.ORCID http://orcid.org/0000-0001-5267-3141
Mirko HollerPaul Scherrer Institut, Villigen, Switzerland. mirko.holler@psi.ch.ORCID http://orcid.org/0000-0001-8141-0148
Tomas AidukasPaul Scherrer Institut, Villigen, Switzerland.
Andreas MenzelPaul Scherrer Institut, Villigen, Switzerland.ORCID http://orcid.org/0000-0002-0489-609X
Manuel Guizar-SicairosPaul Scherrer Institut, Villigen, Switzerland.ORCID http://orcid.org/0000-0002-8293-3634
Jeroen A van BokhovenETH Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-4166-2284
Johannes IhliPaul Scherrer Institut, Villigen, Switzerland. j.ihli@cells.es.ORCID http://orcid.org/0000-0002-9541-5748

Funding

Helmholtz Association VH-NG-21-05
6 · The paper itself

Abstract

Nanoparticles supported on the surface of porous carrier materials are the dominant form of heterogeneous catalysts today. Yet, they suffer from a common deactivation mechanism: the loss of active surface area under industrial use conditions. Deactivation often stems from the sintering of nanoparticles, a mass-transport process whose mechanism and operating length-scale are a topic of controversy. Investigating this process is challenging, requiring not only a behavioral characterization of thousands of individual particles within the spatial confines of a hierarchically structured support but also a characterization of their ensemble behavior and local support interactions. Here, we introduce in situ ptychographic X-ray computed nanotomography as a tool to facilitate this characterization, allowing a local examination of catalysts in their use-geometry under operational-relevant conditions. Applied to methane oxidation over a palladium-on-silica supported catalyst, we reveal two concurrently operating deactivation drivers, short-range ripening and long-range particle migration, each with different temperature and atmosphere dependencies. The latter enables particles to traverse hundreds of nanometers through the support. These observations expand the current understanding of sintering behavior in supported catalysts and demonstrate PXCT's capability to resolve restructuring processes within complex porous materials.

Identifiers

PMID42209475
PMCPMC13389097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.